This document is a monthly report on the Ukrainian pharmaceutical market from March 2016. It provides key macroeconomic indicators for Ukraine from February 2015 to February 2016, including GDP growth, export/import levels, unemployment, and exchange rates. It also gives pharmaceutical industry-specific data over the same time period, such as export/import of pharmaceutical products, retail sales volumes and values, weighted average cost per pack, and the market share of local vs. foreign companies. The report concludes with a summary of recent economic events in Ukraine.
This document provides an overview of the Ukrainian pharmaceutical market and macroeconomic environment in December 2015. It discusses key economic events in Ukraine, including approval of the 2016 budget and tax code. Macroeconomic indicators such as GDP, exports, imports, currency exchange rates, unemployment, and salaries are presented. The pharmaceutical industry section provides data on export and import of pharmaceutical products, retail pharmacy sales volumes and values, and consumer price indexes. Local pharmaceutical companies' market share is also indicated.
This document provides an overview of the Ukrainian pharmaceutical market and macroeconomic environment in December 2015. It discusses key economic events in Ukraine, including approval of the 2016 budget and tax code. Macroeconomic indicators such as GDP, exports, imports, currency exchange rates, unemployment, and salaries are presented. The pharmaceutical industry section provides data on export and import of pharmaceutical products, retail pharmacy sales volumes and values, and consumer price indexes. Local pharmaceutical companies' market share is also indicated.
The pharmaceutical market of Uzbekistan is growing rapidly due to economic development and population growth. The market is currently estimated at $650-700 million but is forecast to double to $1.5 billion by 2020. Local manufacturers currently hold 20% market share while the remaining 80% is held by foreign manufacturers, primarily from Europe, the US, and India. The government is supporting development of domestic production through incentives for foreign investment. Key growth areas are expected to be generics, OTC drugs, and patented brands as consumer purchasing power increases. The market remains underdeveloped with a need for more modern medical facilities and a wider range of products across the country.
The Commonwealth of Independent States (CIS) region has a total GDP of approximately $1.6 trillion and a population of 276 million people. While the original drug market will grow more slowly than generics between 2010-2011, overall growth in original medicines will be positive. The pharmaceutical market is dominated by generic drugs, which make up around 85% of the market. Key players and market structure differ from Western markets, with almost a 50/50 split between Rx and OTC segments and strong local generic production, particularly in Ukraine.
The document summarizes the Ukrainian pharmaceutical market and reasons for starting a business there. It notes that Ukraine has a large pharmaceutical market with over $2.8 billion in retail sales in 2019. The market is growing in both monetary and physical terms. Foreign manufacturers are increasing their market share. Ukraine also offers low costs for doing business, a large workforce, and natural attractions for tourism. The agency provides various consulting services to help companies enter and succeed in the Ukrainian pharmaceutical market.
"Highlights":
Consumer prices are on the rise though annual inflation remains negative
Surplus in the current account for the second consecutive quarter
Lending is back
"In Focus":
Macroeconomic forecasts, by: Igors Kasjanovs
The document summarizes the current state and future prospects of the health care industry in Russia and the region of Tatarstan. It outlines that the Russian market is large and growing, with an aging population driving increased demand. The government is undertaking major reforms through 2020 to encourage local production, R&D, and increase spending. This includes legal changes favoring domestic manufacturers and 4.2 billion in investments. The region of Tatarstan is highlighted as a success story within Russia's health care industry.
Latvijas Banka Monthly Newsletter
Content:
"Highlights":
- Export growth resists adverse external environment
- Money indicators develop favourably
- Economic sentiment tends to improve
"In Focus":
"Allocation of resources in Latvia improved after the crisis" by Konstantīns Beņkovskis
Dear all,
I'm glad to share with you our quarterly report on M&A activities in the industrial segment, the Industrial Insider.
There is a special focus on the Industrial Internet Of Things, IOT.
Should you have any quieries, don't hesitate to contact your local Global M&A Partners' Industrials' sector team representative.
This document provides information about purchasing a 3Com 3C94001 CB 9400 Redundant Power Supply from Launch 3 Telecom. It describes how to purchase the product via phone, email, or by submitting a request for quote online. It also details Launch 3 Telecom's payment and shipping policies, warranty, and additional services offered like repairs.
The pharmaceutical market of Uzbekistan is growing rapidly due to economic development and population growth. The market is currently estimated at $650-700 million but is forecast to double to $1.5 billion by 2020. Local manufacturers currently hold 20% market share while the remaining 80% is held by foreign manufacturers, primarily from Europe, the US, and India. The government is supporting development of domestic production through incentives for foreign investment. Key growth areas are expected to be generics, OTC drugs, and patented brands as consumer purchasing power increases. The market remains underdeveloped with a need for more modern medical facilities and a wider range of products across the country.
The Commonwealth of Independent States (CIS) region has a total GDP of approximately $1.6 trillion and a population of 276 million people. While the original drug market will grow more slowly than generics between 2010-2011, overall growth in original medicines will be positive. The pharmaceutical market is dominated by generic drugs, which make up around 85% of the market. Key players and market structure differ from Western markets, with almost a 50/50 split between Rx and OTC segments and strong local generic production, particularly in Ukraine.
The document summarizes the Ukrainian pharmaceutical market and reasons for starting a business there. It notes that Ukraine has a large pharmaceutical market with over $2.8 billion in retail sales in 2019. The market is growing in both monetary and physical terms. Foreign manufacturers are increasing their market share. Ukraine also offers low costs for doing business, a large workforce, and natural attractions for tourism. The agency provides various consulting services to help companies enter and succeed in the Ukrainian pharmaceutical market.
"Highlights":
Consumer prices are on the rise though annual inflation remains negative
Surplus in the current account for the second consecutive quarter
Lending is back
"In Focus":
Macroeconomic forecasts, by: Igors Kasjanovs
The document summarizes the current state and future prospects of the health care industry in Russia and the region of Tatarstan. It outlines that the Russian market is large and growing, with an aging population driving increased demand. The government is undertaking major reforms through 2020 to encourage local production, R&D, and increase spending. This includes legal changes favoring domestic manufacturers and 4.2 billion in investments. The region of Tatarstan is highlighted as a success story within Russia's health care industry.
Latvijas Banka Monthly Newsletter
Content:
"Highlights":
- Export growth resists adverse external environment
- Money indicators develop favourably
- Economic sentiment tends to improve
"In Focus":
"Allocation of resources in Latvia improved after the crisis" by Konstantīns Beņkovskis
Dear all,
I'm glad to share with you our quarterly report on M&A activities in the industrial segment, the Industrial Insider.
There is a special focus on the Industrial Internet Of Things, IOT.
Should you have any quieries, don't hesitate to contact your local Global M&A Partners' Industrials' sector team representative.
This document provides information about purchasing a 3Com 3C94001 CB 9400 Redundant Power Supply from Launch 3 Telecom. It describes how to purchase the product via phone, email, or by submitting a request for quote online. It also details Launch 3 Telecom's payment and shipping policies, warranty, and additional services offered like repairs.
Pankalla, A. (2011). Pochodzenie psychologii kulturowej Ernesta Boescha. W: T. Rzepa, C.W. Domański. (red.). Na drogach i bezdrożach historii psychologii (s. 83–93). Lublin: Wydawnictwo Uniwersytetu Marii Curie-Skłodowskiej.
Ms Word 2010 Training In Ambala ! Batra Computer Centrejatin batra
Batra Computer Centre is An ISO certified 9001:2008 training Centre in Ambala.
We Provide Best Ms Word 2010 Training in Ambala. BATRA COMPUTER CENTRE provides best training in C, C++, S.E.O, Web Designing, Web Development and So many other courses are available.
Faisal Khan is seeking a position as a Technical Support Engineer or Assistant Manager. He has over 15 years of experience in technical fields such as telecommunications, networking, hardware maintenance, and wireless configuration. He has extensive education including a B.Tech in Telecommunication Technology, a B.Tech Honors in Electronics, and an Associate Engineer diploma in Telecommunications. He also has various technical certifications and training. His previous roles include positions at AutoBar as a Lab In Charge and Customer Support Engineer, Azam Entreprises as a Service Engineer, and United Mobile as the In Charge of Research and Trouble Shooting.
This document provides information about purchasing a 3Com 3C905C-TX II PCI network card from Launch 3 Telecom. It includes details about payment options, same-day shipping and tracking, warranty, and additional repair and installation services offered by Launch 3 Telecom. Contact information is provided to purchase the product or learn more about other telecom equipment and services.
Ukrainian Pharmaceutical Market Monthly - Upharmacia - Jan 2018Eirhub
The document provides an overview of the Ukrainian pharmaceutical market indicators for December 2017. Key points include:
- Pharmaceutical exports grew 6% in 2017 to $193.4 million while imports increased 10% to $1767.3 million.
- Retail sales in values grew 16.5% in 2017 to $2731 million and volumes increased 6% to 1685 million units.
- The average cost of a pharmaceutical pack was $1.47 in 2017.
Ukrainian Pharmaceutical Market Monthly - Upharmacia - Feb 2018Eirhub
This document provides an overview of macroeconomic indicators and pharmaceutical market indicators in Ukraine for January 2018:
- Key macroeconomic indicators such as GDP, exports, imports and industrial production showed growth in January compared to the same period last year, while retail sales and unemployment rate remained stable.
- In the pharmaceutical market, imports increased by 35% in January 2018 compared to January 2017, while retail sales values grew by 21% and volumes by 5%. Exports also increased by 19% year-on-year.
- The average cost of a pharmaceutical pack rose by 15% in January 2018 versus the same month of the previous year, while the consumer price index for pharmaceutical products increased by 6.4% year-
EU: Vaccines For Human Medicine - Market Report. Analysis And Forecast To 2020IndexBox Marketing
This document provides a summary of a sample report on the EU vaccines for human medicine market from 2007 to 2015. It includes key findings on market value, production, imports, and exports in 2015. The executive summary highlights trends in the market and trade balance. The market overview section analyzes the market size, structure, and trade patterns. Tables and figures present historical data on production, trade, prices, and industry structure.
1. Ukraine's economy has been recovering well, with real GDP growth of 3.3% in 2018, driven by strong consumer demand and increasing investments.
2. Key reforms have supported Ukraine's economic recovery and established irreversible steps toward change, while fiscal consolidation has helped prudent debt management.
3. Continued support from economic partners has also contributed to Ukraine's solid economic recovery track over recent years.
1. Ukraine's economy has experienced solid recovery in recent years, with real GDP growth accelerating to 3.3% in 2018. Private consumption has been the key driver of growth.
2. Reforms have supported economic recovery and Ukraine has taken steps to diversify its trade partners, with the EU becoming its largest trading partner. Exports of goods like machinery and metals increased substantially in 2018.
3. The document provides an overview of Ukraine's economy and recent economic performance but cautions that it does not constitute an offer to invest and contains forward-looking statements that may not reflect actual results.
Forecast of development of ukrainian economy in 2017Anatoliy Amelin
The Ukrainian economy showed moderate growth in 2016, with GDP expected to increase 1.1% for the year. Inflation eased to an expected 12% for 2016. Exports stagnated due to relatively low commodity prices. Imports of goods continued to decline, while investment imports increased, signaling positive trends. However, exports declined faster than imports, resulting in a negative trade balance that is expected to widen to $4.9 billion, or 5% of GDP. Overall the recovery remains weak, with investment and domestic demand still low. Continued reforms are needed to strengthen energy independence and improve competitiveness.
This document provides a summary of trends in Israeli exports for the first half of 2016. Some key points:
- Total exports of goods and services were virtually unchanged from the first half of 2015. Exports of goods fell 6% due to declines in industrial exports and diamonds, but this was offset by a 10% increase in exports of services.
- Exports of industrial goods fell 6% overall, driven by sharp declines in electronics, pharmaceuticals, and chemicals exports. Exports of industrial high-tech goods fell 9%.
- Exports declined to all major trading regions, including the European Union (-9%), Asia (-13%), the US (-3%), Latin America (-12%), and Africa (-24%). Declines
This report analyzes the pharmaceutical industry in Uruguay. Key points include:
1) The pharmaceutical sector has shown strong growth over the past decade, outpacing overall manufacturing and the national economy. Exports have also grown faster than total country exports.
2) The industry employs thousands of professionals and technicians and pays above-average wages. There are around 100 pharmaceutical companies in Uruguay, larger than average for national industries.
3) While exports have increased, imports remain greater than exports, resulting in a trade deficit. The main exports are medicines, blood products, and pharmaceutical preparations. Exports go mainly to Latin America.
4) The domestic market includes multinational and national/regional companies
This report analyzes the pharmaceutical industry in Uruguay. Key points include:
1) The pharmaceutical sector has shown strong growth over the past decade, outpacing overall manufacturing and the national economy.
2) Exports of pharmaceutical products have grown but imports remain greater than exports, resulting in a trade deficit. The main exports are medicines, blood products, and pharmaceutical preparations.
3) The domestic market includes multinational and national/regional companies. Sales of national companies have grown similarly to multinationals, though national companies have greater physical unit sales.
1. The document is an investor presentation for Ukraine that provides an overview of the country's economy and highlights its recovery in recent years with robust GDP growth and reforms to tackle corruption.
2. It summarizes Ukraine's key economic statistics and sectors, noting fiscal consolidation efforts, debt management, and support from international partners that have helped economic recovery.
3. Recent milestones include returning to international capital markets, adopting important reforms, and transitioning trade toward the European Union as part of its pro-European path.
Flash Report - Hungarian Inflation - 11 April 2018OTP Bank Ltd.
2%-ra emelkedett az éves bázisú fogyasztói árindex márciusban, azonban továbbra is számos hatás fékezi az árnyomás erősödését. Idén 2% közelében maradhat az infláció, jövőre azonban akár gyors emelkedést is láthatunk, ha az egyszeri tételek hatása kifut.
While the other post-communist countries undertook an effort to meet these expectations, the Ukrainian health system remained virtually unchanged throughout the entire period after the collapse of the Soviet Union. Any changes that were applied were actually apparent and inferior, including when talking about the Ukrainian cancer care system.
2006-2010 Children’s Oncology State Program launched the first ever child-centered separated state program, which full-fledged execution was postponed to 2008. 2010-2016 Oncology National Program faced a considerable funding reduction.
National Cancer Control Strategy was a long-awaited strategic policy since the completion of the previous one in 2016. After a lasting period of negotiation and alignment, the Strategy was a couple of steps from approval, yet the war had started.
The Ukrainian cancer care system evolved very slowly, without the government's significant public interest or strategic focus until 2015-16.
Only at that time did real and practical plans for reforming the health care system begin to mature, when public interest in participating in restructuring state functions and institutions increased significantly.
The global burden of cancer is growing worldwide, with 12.1 million (mln) new cancer cases and 7.1 mln deaths from cancer in 2020 (Source: GLOBOCAN, 2022). 36% of the new cases and 28 % of the deaths occurred in Europe.
Incidence trends for all kinds of cancer have continued to rise in many European countries, although at a slower pace in recent years. Ukraine is classified within the lower-middle-income (LMIC) group and had a population of 44 mln people in 2018.
The cancer incidence rate is distributed unevenly among different population categories in Ukraine. Females are more often diagnosed with cancer than males, and morbidity rates of oncological diseases among urban populations prevail over rural ones.
The cancer care system in Ukraine, inseparable from the general health care system, remained virtually unchanged throughout the entire period after gaining independence in 1991. Yet, healthcare financing reform, launched in 2017, brought positive changes that introduced a diagnosis-related groups-based funding system, set up a strategic purchaser and gave hospitals managerial autonomy to cancer care delivery in 2020.
The care provided for patients with oncological diseases requires a multi-dimensional approach, i.e., different means and methods should be applied at both population and individual levels. These levels are applied sequentially, starting from primary prevention, early detection and screening, diagnostic evaluation, primary, neo-adjuvant and adjuvant treatment, follow-up care, treatment of recurrent cancer, and ending with palliative care and end-of-life care, which are often combined in one.
The burden of cancer is distributed unevenly among the regions of Ukraine. In 2021, Dnipro, Kharkiv, and Lviv regions and Kyiv city had the highest rates of oncological diseases (more than 7,000), while Chernivtsi, Luhansk, and Volyn regions represented the lowest incidence rate, with less than 3,000 new patients with cancer.
The heterogeneity of the incidence rate of cancer could be partly explained by the regional characteristics of the incidence of COVID-19 and the respective change in access to the treatment and detection settings. However, the different levels of medical personnel competence, the presence of modern equipment, and the development of the infrastructure are factors that primarily affect the uneven distribution of the oncology burden among regions of Ukraine.
Uzbekistan Pharmaceutical Country Report 9M 2019Eirhub
The Report uncovers 9M 2019 business trends of the pharmaceutical market in Uzbekistan, reviews its healthcare system, portrays its epidemiology and demographics. It also depicts pharma regulation features in Uzbekistan including a step-by-step process of the marketing authorization procedure for pharma products. It offers insight into the country’s sociopolitical development since independence, describes recent economic trends, and provides the local pharmaceutical sales forecast for the next three years (2019-2021).
Azerbaijan Pharmaceutical Country Report 2019 FYEirhub
The Report uncovers 9M 2019 business trends of the pharmaceutical market in Azerbaijan, reviews its healthcare system, portrays its epidemiology and demographics. It also depicts pharma regulation features in Azerbaijan including a step-by-step process of the marketing authorization procedure for pharma products. It offers insight into the country’s sociopolitical development since independence, describes recent economic trends, and provides the local pharmaceutical sales forecast for the next three years (2019-2021).
Georgia Pharmaceutical Country Report 2019 FYEirhub
The Report uncovers 9M 2019 business trends of the pharmaceutical market in Georgia, reviews its healthcare system, portrays its epidemiology and demographics. It also depicts pharma regulation features in Georgia including a step-by-step process of the marketing authorization procedure for pharma products. It offers insight into the country’s sociopolitical development since independence, describes recent economic trends, and provides the local pharmaceutical sales forecast for the next three years (2019-2021).
Armenia Pharmaceutical Country Report 2019 FYEirhub
The Report uncovers 9M 2019 business trends of the pharmaceutical market in Armenia, reviews its healthcare system, portrays its epidemiology and demographics. It also depicts pharma regulation features in Armenia including a step-by-step process of the marketing authorization procedure for pharma products. It offers insight into the country’s sociopolitical development since independence, describes recent economic trends, and provides the local pharmaceutical sales forecast for the next three years (2019-2021).
The Report uncovers 2019 FY business trends of the pharmaceutical market in Russia, reviews its healthcare system, portrays its epidemiology and demographics. It also depicts pharma regulation features in Russia including a step-by-step process of the marketing authorization procedure for pharma products. It offers insight into the country’s sociopolitical development since independence, describes recent economic trends, and provides the local pharmaceutical sales forecast for the next three years (2019-2021).
Formal registration of companies in Ukraine has many immediate benefits for the companies and for business owners and employees. Legal entities can outlive their founders.
The Ukrainian economy recovered modestly by 2.3% in 2016, with a bumper agriculture harvest leading to stronger growth of 4.8 percent in the fourth quarter. Decisive reforms in the face of unprecedented shocks in 2014 and 2015 helped to stabilize confidence.
As a result, real GDP grew modestly by 2.3 percent in 2016 after contracting by a cumulative 16 percent in the previous two years. Signs of stronger growth of 4.8 percent (y-o-y) emerged in the fourth quarter of 2016. The recovery was supported by a bumper harvest, with agriculture growing by 6 percent in 2016 overall and 18.4 percent (y-o-y) in the fourth quarter.
Pharmaceutical Market in Iran - Opportunities and Market AccessEirhub
Iran Pharmaceutical Market - opportunities and market access. From its well-educated workforce to its dynamic competitive landscape, the Iranian pharmaceutical market has much to offer new entrants (The report is developed by Roland Berger)
The digital marketing industry is changing faster than ever and those who don’t adapt with the times are losing market share. Where should marketers be focusing their efforts? What strategies are the experts seeing get the best results? Get up-to-speed with the latest industry insights, trends and predictions for the future in this panel discussion with some leading digital marketing experts.
Unlock the secrets to creating a standout trade show booth with our comprehensive guide from Blue Atlas Marketing! This presentation is packed with essential tips and innovative strategies to ensure your booth attracts attention, engages visitors, and drives business success. Whether you're a seasoned exhibitor or a first-timer, these expert insights will help you maximize your impact and make a memorable impression in a crowded exhibition hall. Learn how to:
Design an eye-catching and inviting booth
Incorporate interactive elements that engage visitors
Use effective branding and visuals to reinforce your message
Plan your booth layout for maximum traffic flow
Implement technology to enhance the visitor experience
Create memorable experiences that leave a lasting impression
Transform your trade show presence with these proven tactics and ensure your booth stands out from the competition. Download the PDF now and start planning your next successful exhibit!
What Software is Used in Marketing in 2024.Ishaaq6
This paper explores the diverse landscape of marketing software, examining its pivotal role in modern marketing strategies. It provides a comprehensive overview of various types of marketing software tools and platforms essential for enhancing efficiency, optimizing campaigns, and achieving business objectives. Key categories discussed include email marketing software, social media management tools, content management systems (CMS), customer relationship management (CRM) software, search engine optimization (SEO) tools, and marketing automation platforms.
The paper delves into the functionalities, benefits, and examples of each type of software, highlighting their unique contributions to effective marketing practices. It explores the importance of integration and automation in maximizing the impact of these tools, addressing challenges and strategies for seamless implementation across different marketing channels.
Furthermore, the paper examines emerging trends in marketing software, such as AI and machine learning applications, personalization strategies, predictive analytics, and the ethical considerations surrounding data privacy and consumer rights. Case studies illustrate real-world applications and success stories of businesses leveraging marketing software to achieve significant outcomes in their marketing campaigns.
In conclusion, this paper provides valuable insights into the evolving landscape of marketing technology, emphasizing the transformative potential of software solutions in driving innovation, efficiency, and competitive advantage in today's dynamic marketplace.
This description outlines the scope, structure, and focus of the paper, giving readers a clear understanding of what to expect and why the topic of marketing software is important and relevant in contemporary marketing practices.
Can you kickstart content marketing when you have a small team or even a team of one? Why yes, you can! Dennis Shiao, founder of marketing agency Attention Retention will detail how to draw insights from subject matter experts (SMEs) and turn them into articles, bylines, blog posts, social media posts and more. He’ll also share tips on content licensing and how to establish a webinar program. Attend this session to learn how to make an impact with content marketing even when you have a small team and limited resources.
Key Takeaways:
- You don't need a large team to start a content marketing program
- A webinar program yields a "one-to-many" approach to content creation
- Use partnerships and licensing to create new content assets
Boost Your Instagram Views Instantly Proven Free Strategies.InstBlast Marketing
Supercars use advanced materials and tech for top-speed performance. Join Performance Car Exclusive to experience driving excellence.
https://instblast.com/instagram/free-instagram-views
Mastering Local SEO for Service Businesses in the AI Era"" is tailored specifically for local service providers like plumbers, dentists, and others seeking to dominate their local search landscape. This session delves into leveraging AI advancements to enhance your online visibility and search rankings through the Content Factory model, designed for creating high-impact, SEO-driven content. Discover the Dollar-a-Day advertising strategy, a cost-effective approach to boost your local SEO efforts and attract more customers with minimal investment. Gain practical insights on optimizing your online presence to meet the specific needs of local service seekers, ensuring your business not only appears but stands out in local searches. This concise, action-oriented workshop is your roadmap to navigating the complexities of digital marketing in the AI age, driving more leads, conversions, and ultimately, success for your local service business.
Key Takeaways:
Embrace AI for Local SEO: Learn to harness the power of AI technologies to optimize your website and content for local search. Understand the pivotal role AI plays in analyzing search trends and consumer behavior, enabling you to tailor your SEO strategies to meet the specific demands of your target local audience. Leverage the Content Factory Model: Discover the step-by-step process of creating SEO-optimized content at scale. This approach ensures a steady stream of high-quality content that engages local customers and boosts your search rankings. Get an action guide on implementing this model, complete with templates and scheduling strategies to maintain a consistent online presence. Maximize ROI with Dollar-a-Day Advertising: Dive into the cost-effective Dollar-a-Day advertising strategy that amplifies your visibility in local searches without breaking the bank. Learn how to strategically allocate your budget across platforms to target potential local customers effectively. The session includes an action guide on setting up, monitoring, and optimizing your ad campaigns to ensure maximum impact with minimal investment.
Boost Your Instagram Views Instantly Proven Free Strategies.pptxInstBlast Marketing
Join Performance Car Exclusive to drive the finest supercars, engineered with advanced materials and cutting-edge technology for peak performance.
https://instblast.com/instagram/free-instagram-views
Top 10 AI Trends to Watch in 2024 with Intelisyncnehapardhi711
As we advance further into the digital age, artificial intelligence (AI) continues to evolve, shaping various industries and aspects of our daily lives. The advancements in AI for 2024 promise significant transformations across multiple sectors. From agentic AI and open-source AI to AI-powered cybersecurity and sustainability, these trends highlight the growing influence of AI on our world. By staying informed and embracing these trends, businesses and individuals can harness the power of AI to innovate and thrive.
This article explores the top 10 AI trends to watch in 2024, providing an overview, impact, and examples of each trend.
Top 10 AI Trends to Watch in 2024
Trend 1: Agentic AI
Overview of Agentic AI
Agentic AI represents a fundamental shift in artificial intelligence. These AI systems are designed to comprehend complex workflows and pursue difficult objectives autonomously, with minimal human assistance. Essentially, agentic AI functions similarly to human employees, understanding intricate contexts and instructions in normal language, defining goals, deducing subtasks, and adapting actions to changing circumstances.
Impact of Agentic AI
Agentic AI has the potential to drastically alter organizational roles, procedures, and relationships. AI assistants with advanced thinking and planning capabilities can perform tasks previously managed by humans. This shift enhances productivity by fully automating complex processes, freeing workers from repetitive tasks to focus on more critical activities. The ability to adapt quickly to changing circumstances ensures continuous operational improvements.
Examples and Use Cases of Agentic AI
Autonomous Vehicles: Self-driving cars use agentic AI to navigate roads, interpret traffic signals, and make real-time decisions to ensure passenger safety.
Smart Home Devices: AI-powered home assistants, like smart thermostats and security systems, operate autonomously to optimize energy usage and enhance security.
Customer Service Bots: Advanced chatbots handle complex customer queries, provide solutions, and escalate issues to human agents when necessary.
Trend 2: Open Source AI
Overview of Open Source AI
Open-source AI involves freely available source code, encouraging developers to collaborate, use, adapt, and share AI technology. This openness fosters innovation and speeds up the development of practical AI solutions across various sectors, including healthcare, finance, and education.
Impact of Open Source AI
The collaborative nature of open-source AI promotes transparency and facilitates continuous improvement, leading to feature-rich, reliable, and modular solutions. These platforms enable the creation of applications such as real-time fraud detection, medical image analysis, personalized recommendations, and customized learning experiences.
Examples and Use Cases of Open Source AI
TensorFlow: An open-source machine learning framework by Google, widely used for building and deploying AI models.
If you’re at all interested in digital
marketing and in making a name for
your brand online, then it is crucial that
you understand how to properly make
use of content marketing. Content
marketing is currently one of the
biggest trends in digital marketing as a
whole and is an area that many website owners and brands are investing in
heavily right now thanks to the impressive returns that they are seeing.
AI Best Practices for Marketing HUG June 2024Amanda Farrell
During this presentation, the Nextiny marketing team reviews best practices when adopting generative AI into content creation. Join our HUG community to register for more events https://events.hubspot.com/sarasota/
Advanced Storytelling Concepts for MarketersEd Shimp
Every marketer knows you’re supposed to tell a story, but do you know how to tell a story? Do you know why you’re supposed to tell a story? Do you even truly know what a story is? While many marketing presentations emphasize the value of mythic storytelling, the nuts and bolts of actually constructing a story are never explored.
The goal of marketing may be to achieve specific KPIs that drive sales, which is very objective, but the top of the marketing funnel requires a softer approach. In our data-driven results-oriented fast-paced world, marketers must quantify results, but those results will never be achieved unless prospects are first approached with humanity.
There is a common misunderstanding that the so-called “soft skills” of marketing such as language and art are unmeasurable and subjective, but while the objective measures of market research are merely 100 years old, the rules of aesthetics have been perfected over the last 2,500 years.
Great story construction is a skill that requires significant knowledge and practice. This presentation will be a review of the ancient art of story construction.
We will discuss:
• Rhetoric – The art of effective communication
• The Socratic Method – You cannot teach, but you can persuade people to learn
• Plato’s Cave – You sell products, but you market ideas
• Aristotle’s Six Dramatic Elements – The secret recipe for marketing stories
This is for senior marketers who are tasked with creating effective narratives or guiding others in the process. By the end of the session, attendees will have gained the knowledge needed to work storytelling into all phases of the buyer’s journey.
The advent of AI offers marketers unprecedented opportunities to craft personalized and engaging customer experiences, evolving customer engagements from one-sided conversations to interactive dialogues. By leveraging AI, companies can now engage in meaningful dialogues with customers, gaining deep insights into their preferences and delivering customized solutions.
Susan will present case studies illustrating AI's application in enhancing customer interactions across diverse sectors. She'll cover a range of AI tools, including chatbots, voice assistants, predictive analytics, and conversational marketing, demonstrating how these technologies can be woven into marketing strategies to foster personalized customer connections.
Participants will learn about the advantages and hurdles of integrating AI in marketing initiatives, along with actionable advice on starting this transformation. They will understand how AI can automate mundane tasks, refine customer data analysis, and offer personalized experiences on a large scale.
Attendees will come away with an understanding of AI's potential to redefine marketing, equipped with the knowledge and tactics to leverage AI in staying competitive. The talk aims to motivate professionals to adopt AI in enhancing their CX, driving greater customer engagement, loyalty, and business success.
We’ve entered a new era in digital. Search and AI are colliding, in more ways than one. And they all have major implications for marketers.
• SEOs now use AI to optimize content.
• Google now uses AI to generate answers.
• Users are skipping search completely. They can now use AI to get answers. So AI has changed everything …or maybe not. Our audience hasn’t changed. Their information needs haven’t changed. Their perception of quality hasn’t changed. In reality, the most important things haven’t changed at all. In this session, you’ll learn the impact of AI. And you’ll learn ways that AI can make us better at the classic challenges: getting discovered, connecting through content and staying top of mind with the people who matter most. We’ll use timely tools to rebuild timeless foundations. We’ll do better basics, but with the most advanced techniques. Andy will share a set of frameworks, prompts and techniques for better digital basics, using the latest tools of today. And in the end, Andy will consider - in a brief glimpse - what might be the biggest change of all, and how to expand your footprint in the new digital landscape.
Key Takeaways:
How to use AI to optimize your content
How to find topics that algorithms love
How to get AI to mention your content and your brand
Breaking Silos To Break Bank: Shattering The Divide Between Search And SocialNavah Hopkins
At Mozcon 2024 I shared this deck on bridging the divide between search and social. We began by acknowledging that search-first marketers are used to different rules of engagement than social marketers. We also looked at how both channels treat creative, audiences, bidding/budgeting, and AI. We finished by going through how they can win together including UTM audits, harvesting comments from both to inform creative, and allowing for non-login forums to be part of your marketing strategy.
I themed this deck using Baldur's Gate 3 characters: Gale as Search and Astarion as Social
Title: Making Money the Easy Way: A Quick Guide to Generating IncomeWilliamZinsmeister
Welcome to "Making Money the Easy Way: A Quick Guide to Generating Income." This book is designed to provide you with practical, actionable strategies to generate income with minimal effort. Whether you’re looking to supplement your current income or create a full-time revenue stream, this guide covers a variety of methods to help you achieve your financial goals. We will explore opportunities available online, various investment strategies, profitable side hustles, creative approaches, and essential financial tips to ensure sustainable income growth.
Title: Making Money the Easy Way: A Quick Guide to Generating Income
Upharmacia - March 2016
1. Ukrainian Pharmaceutical Market Monthly
Upharmacia
Macroeconomic Environment | Market & Companies News |
Regulatory Updates | Healthcare News
Issue: 03 2016
UPharma Consulting is a consulting company, operating in the healthcare and pharma sectors. Our clients -
pharmaceutical companies, pharmacy chains, distributors, investment funds, banks, and other stakeholders in
the healthcare sector.
UPharma Consulting
Kiev / www.upharma-c.com / mailbox@upharma-c.com / +380 (44) 232-11-42
2. Page 2
Ukrainian Pharmaceutical Market Monthly: March 2016
2015 2016
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
MACROECONOMIC INDICATORS
Q1 Q2 Q3 Q4
GDP (US$ bn) 17.353 20.795 25.552 25.588
growth, % y-o-y -51% -35% -26% -17%
Export of Goods (US$ bn) 2.99 3.45 3.07 2.94 3.09 3.15 3.09 3.35 3.23 3.13 3.36 2.04 3.08
growth, % y-o-y -37% -32% -39% -41% -30% -34% -22% -22% -23% -21% -11% -31% 3%
Import of goods (US$ bn) 2.86 3.17 2.86 2.63 2.76 2.98 3.88 3.24 3.22 3.07 3.12 2.23 2.68
growth, % y-o-y -41% -35% -38% -46% -37% -34% -2% -30% - 27% -27% -32% -26% -6%
Industrial Production Sales (US$ bn) 4.56 5.51 5.91 5.65 5.79 5.71 5.42 5.72 6.29 5.92 6.37 4.93 4.93
growth, % y-o-y -54% -45% -33% -38% -35% -33% -23% -20% -21% -19% -17% -18% 8%
Retail Turnover of Enterprises (US$ bn) 1.44 1.61 1.66 1.94 1.83 1.94 1.88 1.86 2.04 1.80 2.01 1.60 1.50
growth, % y-o-y -61% -56% -40% -35% -38% -41% -32% -38% -31% -33% -29% -19% 4%
Unemployment Rate (%) 2.0 1.9 1.8 1.8 1.7 1.6 1.6 1.5 1.5 1.6 1.9 1.9 1.9
Average Salary (US$) 148 166 176 193 202 202 194 199 207 193 223 180 174
OFFICIAL CURRENCY EXCHANGE RATE
UAH / USD 24.5 23.3 22.7 20.9 21.2 21.8 21.6 21.8 21.8 23.3 23.4 24.3 26.4
UAH / EUR 27.8 25.3 24.5 23.3 23.8 23.9 24.0 24.5 24.6 25.1 25.4 26.3 29.3
PHARMACEUTI CAL INDUSTRY INDICATORS
Export of Pharma Products (mio USD) 12.05 13.37 13.46 13.00 15.36 13.85 9.01 13.79 12.2 11.7 15.77 8.31 13.33
growth, % y-o-y -42% -50% -44% -39% -39% -6% -54% -47% -37% -52% -28% -30% 11%
Import of Pharma Products (mio USD) 114.5 103.3 103.7 84.2 115.0 106.5 93.3 121.1 147.1 141.3 142.1 103.7 145.0
growth, % y-o-y -47% -67% -36% -60% -44% -47% -47% -31% -28% -24% -42% 15% 27%
Pharma Retail Sales, values (mio USD) 177.0 197.6 180.0 193.0 177.7 172.6 177.1 193.2 206.3 196.6 212.3 198.9 176.0
growth, % y-o-y -54% -47% -40% -28% -29% -32% -24% -28% -26% -20% -18% -17% -1%
Pharma Retail Sales, volumes (mio units) 143.9 141.5 122.6 124.5 118.4 119.5 122.5 126.7 130.2 129.0 136.4 133.6 126.8
growth, % y-o-y -15% -21% -20% -11% -9% -10% -8% -11% -5% -4% -5% 1% -12%
WACP (USD) 1.81 1.24 1.41 1.47 1.52 1.48 1.45 1.52 1.58 1.52 1.56 1.49 1.39
growth, % y-o-y -22% -40% -27% -23% -21% -23% -18% -19% -22% -18% -14% -23% -23%
CPI of Ukraine 134.5 145.8 160.9 158.4 157.5 155.3 152.8 151.9 146.4 138.1 134.6 131.9 126.9
Pharmaceutical Products CPI 155.5 170.3 164.7 159.5 153.5 151.8 149.4 145.8 142.1 146.6 143.3 140.3 132.7
Local Companies share, values (%) 38.5 39.6 40.7 41.5 41.7 41.8 41.4 41.4 41.4 41.7 40.9 42.3 42.9
Local Companies share, volumes (%) 75.2 77.1 77.6 77.6 77.9 78.4 78.2 76.5 75.7 75.8 76.7 75.6 76.5
MACROECONOMIC ENVIRONMENT
Description of the indicators:
MACROECONOMIC INDICATORS
GDP (Gross Domestic Product) is an aggregate measure of production equal to the sum of the
gross values added of all resident, institutional units engaged in production (plus any taxes, and
minus any subsidies, on products not included in the value of their outputs) calculated in current
prices. Converted from UAH to USD in accordance with an average official NBU exchange
rate in the corresponding period. Hereinafter: excluding the temporarily occupied territory of
the Autonomous Republic of Crimea and City of Sevastopol, as well as the part of zone of the
antiterrorist operation. Source: State Statistics Service of Ukraine.
Export of Goods is a sale of goods by Ukrainian subjects of foreign economic activities to foreign
subjects of foreign economic activities (including non-cash payment) with or without exportation
of these goods through the customs border of Ukraine, including the re-export of goods. Initially
calculated in USD. Source: State Statistics Service of Ukraine.
Import of Goods is a purchase (including non-cash payment) of goods by Ukrainian subjects
of foreign economic activities in foreign subjects of economic activities with or without the
importation of these goods into the territory of Ukraine, including the purchase of goods for
domestic consumption by establishments and organizations of Ukraine located abroad. Initially
calculated in USD. Source: State Statistics Service of Ukraine.
Industrial Production Sales is the value of industrial goods, which are actually shipped in the
period, as indicated in documents decorated as the basis for calculating with the buyer (customer),
regardless of income payments for them. Converted from UAH to USD in accordance with an
average official NBU exchange rate in the corresponding period. Source: State Statistics Service
of Ukraine.
Retail Turnover of Enterprises is the value of consumer goods sold via retail trade and
restaurants to the population by all operating enterprises. It also includes direct retail sales by
industrial, transport and other non-trade enterprises. In addition, retail turnover includes retail
sales of food products to departments, organizations and enterprises to provide meals to the
people they serve (at sanatoria, children’s care institutions, hospitals, etc.). Reflected in current
prices. Converted from UAH to USD in accordance with an average official NBU exchange rate in
the corresponding period. Source: State Statistics Service of Ukraine.
Unemployment Rate is a ratio (percent) of the unemployed registered at the State Employment
Service to the average annual population of working age. Source: State Statistics Service of
Ukraine.
Average Salary is an average value of remuneration in cash and in kind paid to employees for
time worked or work done. Converted from UAH to USD in accordance with an average official
NBU exchange rate in the corresponding period. Source: State Statistics Service of Ukraine.
Official Currency Exchange Rate is the rate established by the National Bank of Ukraine
under which Ukrainian national currency – UAH (Ukrainian hryvnia) will be exchanged for foreign
currency (USD or EUR). Calculated as average value in the corresponding period. Source: National
Bank of Ukraine.
PHARMACEUTICAL INDUSTRY INDICATORS
Export of Pharma Products is an export of goods related to the group “Pharmaceutical products”
under the Ukrainian Classification of Goods for Foreign Economic Activities. Initially calculated in
USD. Source: State Statistics Service of Ukraine.
Import of Pharma Products is an import of goods related to the group “Pharmaceutical products”
under the Ukrainian Classification of Goods for Foreign Economic Activities. Initially calculated in
USD. Source: State Statistics Service of Ukraine.
Pharma Retail Sales are retail sales of different product categories of “pharmacy basket” (drugs,
medical devices, cosmetics and food supplements) in values and volumes. Converted from UAH
to USD in accordance with an average official NBU exchange rate in the corresponding period.
Source: Morion.
WACP (Weighted average cost of a pack) is a ratio of pharma retail sales in values to pharma
retail sales in volumes.
CPI (Consumer price index) is an indicator of changes at the time of prices and tariffs for
commodities and services being purchased by the population for unproductive consumption
calculated to corresponding month of previous year. Source: State Statistics Service of Ukraine.
Pharma Products CPI is a Consumer price index of “Pharmaceutical products, medical products,
appliances and equipment” group calculated to corresponding month of previous year. Source:
State Statistics Service of Ukraine.
Local Companies Share is the share (percent) of sales related to Ukrainian companies in overall
pharma retail sales in values and volumes. Source: Morion
Table: Key Macroeconomic
Indicators in Ukraine
(Feb 2015-Feb 2016)
3. Page 3
Ukrainian Pharmaceutical Market Monthly: March 2016
KEY ECONOMIC EVENTS
»» Ukraine’s real GDP fell 9.9% y-o-y in 2015, while nominal GDP reached UAH 1,979 bn or USD 89.2 bn by the
average exchange rate. However, the decline dynamics have been decreasing over the quarters of 2015 and in
4Q2015, real GDP decline was 1.4% y-o-y.
»» Economy Ministry of Ukraine reduced its GDP growth forecast from 1.0% to 0.0% y-o-y for 1H2016 due to trade
restrictions imposed by Russia and weak external demand. Later on, the Finance Minister said the government
projects 1% growth in 2016, not 2%, as expected earlier.
»» The National Bank of Ukraine intends to increase international reserves to USD 19.6 bn by the end of 2016, NBU
Head said. The NBU expects to reach funds by restoring relations with the international community. Currently,
the international reserves of Ukraine stand at USD 13.3 bn.
»» Ukraine has reached credit agreement with Japan for USD 200 mio to carry out economic reforms, Finance
Ministry reported.
»» Ukraine and Iran are to start implementing joint projects in agricultural sector and continue cooperation in
banking sector. Ukraine also proposed Iranian investors to participate in privatization of Ukrainian enterprises
and investing in forestry and fishing sector.
»» Fiscal revenues to the consolidated budget of Ukraine in Jan-Feb 2016 increased by 33.6% y-o-y to UAH 83.4
bn.
»» European Commission will recommend abolishing visas for Ukrainians in Apr, Jean-Claude Juncker said. In Mar,
the Ukrainian parliament has adopted the last law of “visa-free” package.
»» In Feb, industrial output in Ukraine increased by 7.6% y-o-y. The main drivers for growth were metals, mining
and machinery. Luhansk region recovered its industry by 2.5x y-o-y, while Donetsk region increased output by
26.9% y-o-y.
177.0
197.6
180.0
193.0
177.7
172.6
177.1
193.2
206.3
196.6 212.3 198.9
176.0
143.9
141.5
122.6
124.5
118.4
119.5
122.5
126.7
130.2 129.0
136.4
133.6
126.8
100
110
120
130
140
150
160
100
120
140
160
180
200
220
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
Pharma retail sales
2015 2016
Volumes (mio units)
Values (mio USD)
12.1
13.4 13.5 13.0
15.4
13.9
9.0
13.8
12.2
11.7
15.8
8.3
13.3
114.5
103.4 103.7
84.3
115.0
106.6
93.3
122.2
147.1
141.3
142.1
103.7
145.0
0
20
40
60
80
100
120
140
160
0
4
8
12
16
20
24
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
Ukraine's Internation trade
in pharma production
2015 2016
Export
Import
4.56
5.51
5.91
5.65
5.80 5.71
5.43
5.72
6.29
5.92
6.37
4.93 4.93
1.44
1.61 1.66
1.94
1.83
1.94
1.88 1.86
2.04
1.80
2.01
1.60
1.50
0.0
0.5
1.0
1.5
2.0
2.5
3.0
0
1
2
3
4
5
6
7
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
Industrial production sales &
Retail turnover of enterprises surplus
2015 2016
Retail turnover of enterprises
Industrial producƟon sales
24.5 23.3 22.7
20.9 21.2 21.8 21.6 21.8 21.8
23.3 23.4 24.3
26.4
29.0
29.5
26.9
25.5 24.9
26.1 25.9 26.1
24.6 25.1 25.4
26.3
29.3
134.5
145.8
160.9 158.4 157.5 155.3 152.8 151.9
146.4 146.6
143.3
140.3
132.7
0
20
40
60
80
100
120
140
160
0
5
10
15
20
25
30
35
40
45
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
2015 2016
vs. Consumer Price Index
Official Currency Exchange Rates
Consumer Price Index
UAH / €
UAH / $
4. RECRUITING &
EXECUTIVE
SEARCH
We recruit pharma people in the
CIS region and focus on:
> Sales & Marketing
> Regulatory Affairs
> Quality Assurance
> Finances
> Operations
> Administration
We aim to be your trusted advisor
in People Management
Anastasiya MAXIMENKO
Partner, HR-Consulting
AMaximenko@upharma-c.com
+380 (44) 232-11-43
+380 (97) 953-68-14
5. Page 5
Ukrainian Pharmaceutical Market Monthly: March 2016
MARKET & COMPANIES NEWS
Sanofi Ukraine
appointed new
Director
On Mar 1, Sanofi announced the
appointment of Guilhem Granier
as the Director of Sanofi Ukraine
and General Manager of the Rx
department. Mr. Granier has
replaced Jean-Paul Scheuer, who
has been heading the company
for seven years.
Guilhem Granier joined Sanofi
in 2000. In 2007, he had been
appointed as the company’s
Business Unit Director in Tunisia,
while in 2010 he became the
General Manager in Tunisia
and Libya. His last position was
Business Excellence Director of
Intercontinental region (Africa
States, Middle East, Eurasia and
South Asia).
“I have a quite diverse experience
of working in crisis conditions,
which I will try to use at my new
position in Ukraine,” Mr. Granier
said. “Certainly, my further work
will be based on what Jean-Paul
and Sanofi Ukraine’s team have
already built.”
Jean-Paul Scheuer will continue
working as County Chair of Sanofi
Gulf and Yemen region.
Liktravy reported
UAH 13.6 mio
profit in 2015
The biggest Ukrainian producer of
herbal preparations Liktravy has
finished 2015 with UAH 13.6 mio
net profit, the company’s officials
reported. The company’s profit
raised almost four times from
UAH 3.5 mio in 2014.
Liktravy produces more than
70 names of brands. Hallmarks
of the company are medicinal
herbs and phytotea. Liktravy’s
assets amounted UAH 180.2
mio, 99.35% of which are
owned by German company MB
Beteiligungs Gmbh.
GSK restricts
supply of
Infanrix™
vaccines to Ukraine
GSK Ukraine announced the
temporary restriction of supply
of Infanrix™ vaccines (Infanrix™
HEXA, Infanrix™ IPV, Infanrix™)
containing pertussis component
to Ukraine due to increased
global demand in ones and
limited production capacity.
The restrictions will apply to
requirements of the national
immunization program as well as
to supply to private clinics and
pharmacies. All other vaccines
of the company are supplied in
Ukraine as usual.
“The restrictions do not connect
with the issues of quality or
safety of our vaccines,” GSK’s
officials said. “We expect the
restrictions will apply only
shortly. But the terms could
change in respond to the external
environment.”
Later on, the company stated it
plans to register new vaccines
in Ukraine to eliminate the
deficit of vaccines containing
pertussis component. In case if
other companies are not able to
carry out the supply, GSK will
take steps to find an acceptable
solution, the company said.
Antibiotice will open
representative office
in Ukraine
Romanian pharmaceutical
company Antibiotice will open its
representative office in Vinnytsia
in 2016. The corresponding
agreement was reached between
the GM of the company and the
Head of Vinnytsia Region State
Administration.
Antibiotice was founded in
1995 and now develops and
produces generic drugs for
human use veterinary drugs and
the active ingredient Nystatin.
The company’s portfolio consists
of 148 products, which are
mainly intended for patients with
infectious diseases, but also for
cardiovascular, dermatological,
oncological, digestive and
central nervous system related
pathologies. Antibiotice is actively
expanding external markets; in
2014 the company exported
production for USD 25.6 mio.
InterChem is
developing
three new molecules
InterChem pharmaceutical
company has three molecules
under development, the Director
of the company Anatoliy Reder
said. Lately, InterChem has
finished another phase of clinical
trials of a product against a
sore throat. Nootropic drug for
memory restore is also in the
phase of clinical trials. InterChem
expects to register new medicines
following bioequivalence
procedure.
InterChem was the 25th
company on the Ukrainian
pharmaceutical market by sales
in 2015. The company’s primary
specialization is drugs for
nervous and respiratory systems.
The company plans to put its
new production facilities into
operation in Apr 2016. Currently,
InterChem considers the access
to the markets of East Africa,
particularly Kenya.
Indar received GMP
certificate in Brazil
National Health Surveillance
Agency of Brazil (ANVISA)
has granted Ukrainian insulin
producer Indar the International
6. Page 6
Ukrainian Pharmaceutical Market Monthly: March 2016
GMP certificate. Indar has been
supplying recombinant insulins
in the form of ready-made
medicines in Brazil, where they are
prescribed to adults and children.
It was reported, that the company
had planned to put into operation
its insulin-manufacturing site in
Brazil in 2016.
Indar is the only insulin producer
in Ukraine, obtaining a full cycle
manufacturing of the preparation
– from substances to finished
dosage forms. Since 2012, 70.7%
of Indar’s shares are owned by the
State company “Ukrmedprom”.
Arterium
Corporation
launches a pregabalin drug
Ukraine’s 3rd
biggest
pharmaceutical company
Arterium Corporation has
launched Gabana™ (pregabalin)
for the treatment of neuropathic
pain. The drug is produced under
GMP standards at the facilities of
PJSC Kievmedpreparat (part of
Arterium Corporation). Gabana™
is a Rx drug, which claims to be
cost-effective for patients as
other pregabalin analogs are quite
expensive.
Arterium did not change its
positions on the Ukrainian
pharmaceutical market in 2015
despite the bankruptcy of the
company’s owner “Finance and
Credit” Group. The company’s
portfolio consists of more than
140 brands with an emphasis on
cardiovascular and antiinfective
groups.
Dr. Reddy’s
will launch new
drugs in Ukraine
Indian Dr. Reddy’s remains
optimistic regarding Ukrainian
pharmaceutical market
and continues its business
development in the country,
Executive VP of the company M.
V. Ramana said. The company
intends to strengthen its positions
in Ukraine by launching innovative
products. Thus, Dr. Reddy’s plans
to register molecules for the
treatment of cardiovascular and
neurological diseases as well as
new oncology drugs.
Dr. Reddy’s was 29th
company
in the Ukrainian pharmaceutical
market by sales in 2015.
AstraZeneca
Ukraine will
expand its oncological portfolio
AstraZeneca announced the
launch of Lynparza™ (olaparib)
for the treatment of ovarian
cancer onto Ukrainian market.
“Launching olaparib is a
major step towards achieving
leadership in the oncology field,”
the Director of AstraZeneca in
Ukraine Evgeniy Gaidukov said.
“The drug is at the forefront
in AstraZeneca’s oncological
portfolio and can significantly
improve the patients’ life.’
Olaparib is a poly (ADP-ribose)
polymerase inhibitor affecting
DNA repair processes. The drug
was endorsed for registration in
Ukraine in Nov 2015.
The government
endorsed Biofarma
to export blood
preparations
The Cabinet of Ministers of
Ukraine approved the MOH’s
proposition to provide PJSC
Biofarma, and Biofarma Plasma
LLC exclusive authority to sell
donor blood components and
made of blood preparations
outside Ukraine.
Biofarma is one of the biggest
pharmaceutical companies in
Ukraine producing more than
130 brands in 11 pharmaceutical
groups. The company’s key
activity is the manufacturing of
high-technological preparations
made of donor blood as well as
recombinant drugs and bacterial
preparations.
REGULATORY UPDATES
The Essential Documents in the
Sphere of the National Essential
Medicines List Have Been
Disclosed to the Public
The Order of MOH № 84 dated
11.02.2015, with which the
Regulation on the National List
of Essential Medicines and
the Regulation on the Expert
Committee on the Selection and
Use of Essential Medicines has
been approved.
The said provision establishes
that the drugs will be included
in the National List of Essential
Medicines (hereinafter - the
National List), taking into
account population incidence
rates, prevalence of disease
and mortality, evidence of the
comparative effectiveness
(performance), safety and cost-
effectiveness of medicines, as well
as industry standards in terms
of health and level of funding for
health care. The structure and
contents of national lists will be
based on the latest edition of the
Provided by
7. Page 7
Ukrainian Pharmaceutical Market Monthly: March 2016
Basic List of Essential Medicines
recommended by WHO.
The next working step is to
create a competitive commission
for the formation of an Expert
Committee, which consists of
12-18 people, and the selection of
committee members on the basis
of equal access of candidates to
participate in the competition.
Once an expert committee under
the MOH is established, work
concerning the selection of drugs
to be included in the National
List will be conducted by them.
The drugs will be included in the
National List for International
Nonproprietary Names. National
List updates will be carried out
once a year.
Interested individuals and legal
entities can apply with a package
of necessary documents for
inclusion of drugs in the National
List of Medicines. To this end,
the development and public
discussion of the Regulation
on the conduct of medicines
selection for inclusion in the
National List, which will be
approved by order of the MOH,
as well as the application form
and its requirements is being
continued.
See all news on regulatory
updates on the Legal Alliance
website.
Parliament will consider healthcare
Draft Laws on Apr 12
Parliament will consider Draft
healthcare Laws on Apr 12
Ukrainian Parliament will hold
a thematic session to consider
Draft Laws in the sphere of
healthcare on Apr 12, the Speaker
Volodymyr Groysman said on Mar
28.
“I’m asking thw Apparatus of the
Parliament to process the list
of laws and positions on their
support for the next plenary
week,” Mr. Groysman said. “I would
also ask to connect associations
and learn the position of regional,
local councils on what should be
improved in healthcare.”
Previously, Parliamentary
Committee had approved the
Draft Law “On autonomation
of healthcare establishments”,
which is expected to start the
process of reformation of the
National healthcare system. The
Draft Laws on transplantation
and increase of wages to medical
workers are also to be considered
by deputies.
Parliamentary Committee rejected
the Draft Law to reduce drugs
prices
On Mar 30, during the meeting
of the Parliamentary Committee
of Public Health, the PMs
considered the Draft Law 1376
“On Amendments to the Tax
Code of Ukraine and some other
legislative acts of Ukraine (on
reducing prices on drugs).” The
document proposed to establish
extra charges for distributors and
retailers at the level of 3% and 5%,
respectively, for all medicines and
medical devices.
The Committee Members rejected
the Draft Law, stating that it is
contrary to current legislation.
Moreover, it could provoke the
extinction of many drugs on
the pharmaceutical market of
Ukraine. According to PM Irina
Sysoenko, the only way to solve
pricing issue is to implement
reimbursement mechanism.
HEALTHCARE NEWS
Ukraine’s PM: Minimal guarantee
level of free medical services to be
introduced this year
The government plans to
implement the guaranteed
level of free medical services in
2016 within healthcare system
reformation, the PM of Ukraine
Arseniy Yatsenyuk stated. “Free
health care services should
be provided through the State
Medical Insurance Fund, where
each Ukrainian citizen must be
insured,” Mr. Yatsenyuk said.
MOH and insulin producers signed
Memorandum of understanding
The MOH and the range of
insulin producers have signed the
Memorandum of Understanding
defining the order of joint
activities aimed at providing of
Ukrainians with insulin drugs as
well as successful implementation
of the pilot project on insulin
reimbursement.
The following companies have
signed the Memorandum: Farmak,
Indar, Sanofi-Aventis Ukraine LLC,
Bioton S.A., Eli Lilly Vostok S.A.,
Novo Nordisk A/T, Pharma Life
LLC. The pilot project is expected
to start acting since Apr 1, 2016.
8. Page 8
Ukrainian Pharmaceutical Market Monthly: March 2016
The MOH is discussing
development of new drug policy
Among the MOH’s main tasks
is the provision of access to
drugs, containing narcotic and
psychotropic substances to
patients requiring them, the
Healthcare Minister Kvitashvili
said during the public discussion
on 03/03/2016. The issue
of decriminalization of drugs
consumers, which keep them in
small amounts without intent
to sell, is also essential, Mr.
Kvatashvili said.
Excessive over-regulation
of medical circulation of
preparations leads to significantly
limited access to pain relief for
patients with severe diseases,
mental illness and addiction, the
acting Head of State Drug Control
Service stressed.
All members of the discussion
concluded the Ukraine’s need to
reconsider approaches in state
drug policy towards humanization
and efficiency.
The Cabinet of Ministers
announced tasks in HC for 2016
The Ukrainian government
announced 379 tasks to be
done by the Cabinet of Ministers
together with the President and
the Parliament in 2016. The
following functions defined sphere
of healthcare:
»» “Money follows the patient” –
creation of a new system of
medical services financing.
Finance Ministry and Ministry
of Social Policy will need
to develop legislative acts
to implement the state-
guaranteed package of
health services. The task
also foresees the creation of
National Agency on healthcare
financing.
»» The new system of public
procurement of drugs – until
Aug 31 the MoH and Economic
Development Ministry must
develop legislative acts
regulating the centralized
procurement organization in
healthcare.
»» The new primary medical care
– developing a new model of
primary healthcare provision
»» Public health – protection
and strengthening of national
health.
»» The availability of high-
quality and efficient drugs
– adoption of National policy
on drugs following the WHO
recommendations.
Antituberculosis program for
2017-2021 is under development
Ukraine is developing the program
on fighting tuberculosis for
2017-2021, which considers
new approaches to the disease
treatment, the Director of
Ukrainian Center for controlling
socially dangerous diseases of the
MOH Natalia Nizova said. Ukraine
has 28 ths officially registered
persons with tuberculosis while
50% of tuberculosis hospitals
do not meet the requirements of
infection control.
Israeli experts are ready to share
experience on development of
efficient HC system with Ukraine
Israeli experts and physicians are
ready to share with Ukraine the
experience on the development
of efficient healthcare system,
but the reforms should be carried
by Ukrainian colleagues, Israel’s
ambassador to Ukraine Eliav
Belotserkovsky said.
Israeli partners intend to hold
lectures in establishments
of medical education in
Ukraine and start elaborating
with Parliamentary Public
Health Committee. Ukrainian
professionals also expect to
take over the practices of family
doctors and primary care.
9. Business
Consulting
HR-Consulting
Market
Access
Business
Education
Support of M&A Deals / Pre-investment Due Diligence
Commercial Audit / Business Diagnostics
FCPA Audit / Reputational Audit
Executive Search / Recuiting
Organizational Consulting / Personnel Assessment
Outplacement
Launch Planning / Marketing Analysis & Planning
Regulatory Environment Audit / Business Modelling
Analysis of Prescribers and Consumers
Business Training for Pharmaceutical Companies:
Strategy / Change Management
New Launches / Marketing
UPharma Consulting is
a consulting company,
operating in the healthcare
and pharma sectors. Our
clients - pharmaceutical
companies, pharmacy
chains, distributors,
investment funds, banks,
and other stakeholders.
UPharma Consulting
21st
Marshal Tymoshenko str.,
building 7, office 5
Kiev, 04212
Ukraine
+380 (44) 232 1142
+380 (44) 232 1143
www.upharma-c.com
mailbox@upharma-c.com
Subscribe to
Upharmacia
instantly!